Male Fertility and Sperm Cryopreservation
Launched by UNIVERSITY OF TENNESSEE · Apr 27, 2015
Trial Information
Current as of April 24, 2025
Withdrawn
Keywords
ClinConnect Summary
RATIONALE: In June 2006, the American Society of Clinical Oncology published a series of recommendations on fertility preservation for patients with cancer, concluding that "To preserve the full range of options, fertility preservation, approaches should be considered as early as possible during treatment planning". These guidelines reflect the greater attention that has been given in recent years to the fertility complications that can occur as a result of cancer treatment (eg, chemotherapies and radiation).
Different cancer treatments such as cytotoxic therapy can lead to azoospermia and...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • male, aged 13 years or older,
- • diagnosed with cancer, but not yet undergoing therapy
- • willing to participate in this clinical trial
- • signed Informed consent document
- Exclusion Criteria:
- • under 13 years old
- • have already begun Chemo or radiotherapy
Trial Officials
Laura Detti, M.D.
Principal Investigator
Associate Professor, UTennessee Health Science Center
About University Of Tennessee
The University of Tennessee is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to improving patient outcomes and fostering scientific discovery, the university engages in a diverse range of studies that encompass various medical disciplines. Leveraging its extensive resources, expert faculty, and state-of-the-art facilities, the University of Tennessee collaborates with healthcare professionals and industry partners to translate research findings into practical applications. Through rigorous ethical standards and a patient-centered approach, the university aims to contribute significantly to the field of medicine and enhance the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials